Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
Despite major advances in cardiovascular research over the past decade, women with type 2 diabetes have a high risk of cardiovascular events. Several factors contribute to the poor prognosis for women, including higher levels of frailty and comorbidities, but their cardiovascular risk is underestima...
Enregistré dans:
Auteurs principaux: | Giuseppe Galati, Pierre Sabouret, Olga Germanova, Deepak L Bhatt |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ec4ff1ff8efb43c3b5eb45f3380f1784 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
par: Anna Meta Dyrvig Kristensen, et autres
Publié: (2020) -
Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
par: Muhammad Shahzeb Khan, et autres
Publié: (2019) -
Heart failure and central sleep apnea in the era of implantable recorders
par: Irina Cabac-pogorevici, et autres
Publié: (2021) -
A New Era in Zero X-ray Ablation
par: Giuseppe Mascia, et autres
Publié: (2020) -
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
par: Giuseppe MC Rosano, et autres
Publié: (2019)